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and the well-known tendency of
particular maladies to show breed-
specificity can be used to infer
likely sharing of descent of the
causative alleles. As made clear in
the volume under review, this is as
true of major-gene diseases such
as copper toxicosis and various
retinopathies, as it is of the more
complex and more prevalent
cardiomyopathies, cancers, and
dermatitis.
Conduction of clinical trials is
also much more difficult in
humans. Human healthcare is
expensive, and members of this
species show a predilection
toward law suits when things don’t
go quite right. By contrast, dog
trials can be relatively quick to
perform, study populations are
fairly easily recruited, and it turns
out the physiology and
endocrinology of disease is often
strikingly similar between the large
mammals. Though not discussed
in the volume, pharmacogenetics
may get a boost from dogs, as
refractoriness to drugs often
displays similar levels as observed
in humans — for example,
veterinarians will tell you that
approximately ten percent of
epileptics are non-responsive to
the commonly used
pharmacological agents — and
there is less of the litigious
downside to mis-prediction. Gene
therapy, too, has definite upsides
in canines as various gene delivery
approaches can be assessed in
dogs for many treatable rare
disorders that can actually be bred
in study colonies.
Why not mice? The simple
answer is that most of the complex
diseases we see in dogs are
naturally occurring, as opposed to
having been engineered into caged
animals. Our pets share our
toxicological and, to some extent,
nutritional environment, and the
similarities in the time of onset and
etiology of so many of the major
diseases is striking. It turns out,
too, that our genomes are more
similar at the level of gene content
and sequence than those of
rodents, even though rodents
share a more recent common
ancestor with Homo sapiens than
do dogs. This is because of an
accelerated rate of divergence in
the smaller mammals.
Nevertheless, many biomedical
researchers, particularly those who
serve on study sections, will point
out that there are few remaining
limits to gene discovery in humans,
and what we really need is a model
organism that we can manipulate
genetically in order to test specific
hypotheses. Transgenic dogs
expressing GFP-tagged proteins
aren’t likely to be running around
any time soon — though a dog
with fluorescent green eyes may
go down well with children — while
biochemistry and molecular cell
biology lag well behind the mouse.
Dogs are unlikely ever to become a
model for the annotation of gene
function.
Which brings us back to the
reason why there are dogs in the
first place: they are physically
diverse and attractive, and
behaviorally fascinating and useful.
Another reason to buy The Dog
and its Genome is for the superb
28-page appendix of paintings of
145 breeds. It is remarkable given
the variety of shapes and sizes
how little attention evolutionary
developmental biologists have
given to the species. Aside from a
few groups performing quantitative
trait loci (QTL) mapping within
breeds, there is little data on the
genetic basis of allometric
differentiation, despite the fact that
such studies are likely to provide a
perspective quite distinct from the
one derived from comparison of
invertebrate development [2].
Regarding behavior, dogs are even
more compelling. Whether it is
herding tendencies or separation
anxiety, the neurochemistry of
seizures, or simply the biology of
unconditional love, dogs present
opportunities for study that are
second to none.
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What turned you on to biology in
the first place? As an engineering
student in college, my interests
were drifting from nuclear physics
to chemistry to biochemistry when,
in my third year, I took my first ever
biology class, and suddenly the
‘lights came on’. It was the lac
operon that did it, and genetics
has been my passion ever since.
Believe it or not, I’d never been
exposed to biology previously,
even in high school where the
Jesuit teachers, mainly interested
in philosophy and logic, pointed us
toward mathematics and physics,
and placed a low relative value on
biology. Obviously, this was a
rather unfortunate miscalculation
on their part and I’m sure it robbed
a lot of promising students of an
opportunity to consider a
rewarding and worthwhile career
path in biology. 
Do you have a scientific hero?
Barbara McClintock, because she
never let anything or anybody
stand in the way of pursuing
research that she believed to be
important and worthwhile. Her
love of science, her
openmindedness, and the way
she balanced scientifically
rigorous analysis with intuition
and creative thought have long
been an inspiration to me.
What paper influenced you
most? Unquestionably that would
be R. Alexander Brink’s 1960
article ‘Paramutation and
chromosome organization’ (Q.
Rev. Biol. 35, 120), in which he
proposed that chromosomes have
a ‘paragenetic’ function in addition
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R39to their genetic one. I first read it in
1991 or thereabouts, when I was
struggling to make sense of the
complexity of epigenetic
behaviours we had begun to
observe in petunia, associated
with the cosuppression of flower
color genes by homologous
transgenes designed for pigment
overexpression. Brink’s was the
first clear statement of the role of
what we now call epigenetics in
the control of gene expression and
development in higher organisms.
The concept was far ahead of its
time and was long ignored, but his
views now seem to be becoming
mainstream, with the increasing
recognition that mitotically
transmissible chromatin states
play key roles in diverse aspects
of physiology and development in
a wide range of organisms.
What was your favourite
conference? The DNA Insertions
meeting, organized by Ahmad
Bukhari, Jim Shapiro and Sankar
Adhya at the Cold Spring Harbor
Lab in 1976. It was my incredible
good fortune that my first scientific
conference as a graduate student
was the meeting that first brought
together eukaryotic and
prokaryotic geneticists to explore
the ‘rediscovery’ of transposable
elements, a great creative
upheaval that tore down
conservative assumptions about
the nature and evolution of genes
and genomes. It was a remarkable
and invigorating meeting that had
a huge impact on my development
as a scientist.
Any strong views on journals
and the peer review system?
Anyone willing to offer an opinion
on the suitability of a manuscript
for publication should also be
willing to back up their views with
factual arguments and to stand by
their conclusions without hiding
behind a veil of anonymity. This is
just my personal opinion, and of
course, such a change could only
come about if consensus support
for it emerged, and I don’t see
that happening any time soon. 
What big questions interest you
in the long term? I am intrigued
by two very ‘big’ questions: As a
geneticist, I’d like to know to whatextent does epigenetic inheritance
contribute to evolution? As a plant
biologist, I’d like to know how
plants process information, how
they store, retrieve and act upon
it, and at what level of
sophistication they integrate these
processes. The first question has
to do with a rather dicey notion:
that of imprinting one’s genome in
hopes of transmitting information
that would give your progeny an
edge to help them survive after
you’re dead and gone. And the
second is a question about how
other forms of life might ‘think’.
From an anthropomorphic
perspective, we tend to have a
rather fixed expectation about
what constitutes thinking, but
from the perspective of an
unbiased, non-human observer,
‘thinking’ might be described as a
complex process that integrates
and evaluates information in a
sophisticated manner that results
in a novel, unprogrammed
response. Is it possible that
organisms other than animals —
plants, say — have some such
capacity? What might we learn
from mechanisms of ‘thinking’
that differ from our own? 
What do you think about the
desire in some parts for
primary material to be freely
available? Total open access is
an attractive goal — until one
thinks it through fully. Science is
much more than just doing
research and publishing it — the
work has to be funded first, and
for that to happen scientists have
to educate the public, their
elected representatives, and
policy makers. More importantly,
science is an integral part of
modern society, and funds
derived from publishing by not-
for-profit scientific societies
provides many benefits. As
scientists, we have
responsibilities to provide
thoughtful analysis on important
issues: Should intelligent design
be taught alongside evolution?
Should genetically modified foods
be sold? Labeled? Regulated? If
so, in what manner and with what
level of caution? Every scientist
can identify many such questions
to which they could contribute
meaningfully, but getting the rightexpertise to the right place at the
right time to be effective and to
truly influence societal outcomes
is not easy. Many professional
scientific societies work
vigorously to help science meet
its societal obligations, linking
appropriate expertise with
important issues and policy
makers, fostering better public
education and understanding of
science, as well as advocating for
science funding. If scientific
publishing is going to be
subscription-free, will we have to
do without these important
contributions of the scientific
societies? It would be naïve to
suggest that professional
membership fees can replace
publication revenues. The risk of
catastrophic loss of valuable
institutions is substantial and real,
in my view. 
What has been your biggest
mistake in research? Not paying
closer attention to Bill Dougherty,
who suggested by 1995 several
key features of the mechanism we
now call RNA interference: that
cosuppression by sense
transgenes involves an RNA-
dependent RNA polymerase which
copies overly abundant transcripts
to produce antisense ‘copy RNA’
(cRNA) molecules; that cRNAs pair
with homologous target RNAs to
form double-stranded RNA
(dsRNA) that could then be
cleaved by dsRNases; that cRNAs
could be as short as 20
nucleotides and still retain gene
specificity; and that DNA
methylation associated with
cosuppression could be explained
by short cRNAs entering the
nucleus and directing methylation
of homologous sequences. All this
was suggested several years
before the first report of RNA
interference in worms, but it was
just one of a number of
hypotheses in vogue at the time
among plant and fungal
geneticists, and unfortunately Bill
left science soon thereafter and so
did not pursue his ideas
experimentally. I certainly wish I
had!
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